Wegovy (semaglutide) Injection recall
FDA recall D-0245-2026 · initiated Dec 19, 2025
Novo Nordisk Inc. recalled Wegovy (semaglutide) Injection in Dec 2025 — an FDA Class II recall (D-0245-2026) because Presence of Particulate Matter: Hair was found in a prefilled syringe.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of Particulate Matter: Hair was found in a prefilled syringe
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: N/A
Details
- Product
- Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
- Recalling company
- Novo Nordisk
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide within the United States.
- Initiated
- Dec 19, 2025
- FDA report date
- Jan 7, 2026
Frequently asked
- Was Wegovy (semaglutide) Injection recalled?
- Novo Nordisk Inc. recalled Wegovy (semaglutide) Injection in Dec 2025 — an FDA Class II recall (D-0245-2026) because Presence of Particulate Matter: Hair was found in a prefilled syringe. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Wegovy (semaglutide) Injection recalled?
- Per the FDA enforcement record, the reason for recall D-0245-2026 was: Presence of Particulate Matter: Hair was found in a prefilled syringe
- Is a recalled Wegovy (semaglutide) Injection dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Wegovy (semaglutide) Injection are affected?
- Distributed: Nationwide within the United States.. The recall covers these lots — Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0245-2026.